188 related articles for article (PubMed ID: 23145966)
1. Continuous glucose monitoring: a valuable monitoring tool for management of hypoglycemia during chemotherapy for acute lymphoblastic leukemia.
Visavachaipan N; Aledo A; Franklin BH; Brar PC
Diabetes Technol Ther; 2013 Jan; 15(1):97-100. PubMed ID: 23145966
[TBL] [Abstract][Full Text] [Related]
2. The association between fasting hypoglycemia and methylated mercaptopurine metabolites in children with acute lymphoblastic leukemia.
Melachuri S; Gandrud L; Bostrom B
Pediatr Blood Cancer; 2014 Jun; 61(6):1003-6. PubMed ID: 24415675
[TBL] [Abstract][Full Text] [Related]
3. Application of the Continuous Glucose Monitoring System (CGMS) in the 72-hour fast test in two patients with hypoglycemia.
Wang X
Diabetes Technol Ther; 2004 Dec; 6(6):883-6. PubMed ID: 15684643
[TBL] [Abstract][Full Text] [Related]
4. Symptomatic hypoglycemia in children receiving oral purine analogues for treatment of childhood acute lymphoblastic leukemia.
Ziino O; Russo D; Orlando MA; Benigno V; Locatelli F; Aricò M
Med Pediatr Oncol; 2002 Jul; 39(1):32-4. PubMed ID: 12116076
[TBL] [Abstract][Full Text] [Related]
5. Severe hypoglycemic seizures in a child receiving 6-mercaptopurine.
El-Bitar MK; Muwakkit SA; Dabbagh O
J Pediatr Hematol Oncol; 2011 Mar; 33(2):e75-6. PubMed ID: 21343747
[TBL] [Abstract][Full Text] [Related]
6. [Usefulness of continuous glucose monitoring system in detection of hypoglycaemic episodes in patients with diabetes in course of chronic pancreatitis].
Ruxer J; Mozdzan M; Loba J; Barański M; Ruxer M; Markuszewski L
Pol Arch Med Wewn; 2005 Oct; 114(4):953-7. PubMed ID: 16789520
[TBL] [Abstract][Full Text] [Related]
7. Fasting hypoglycemia is common during maintenance therapy for childhood acute lymphoblastic leukemia.
Halonen P; Salo MK; Mäkipernaa A
J Pediatr; 2001 Mar; 138(3):428-31. PubMed ID: 11241057
[TBL] [Abstract][Full Text] [Related]
8. Symptomatic hypoglycemia: an unusual side effect of oral purine analogues for treatment of ALL.
Bay A; Oner AF; Cesur Y; Dogan M; Etlik O; Sanli F
Pediatr Blood Cancer; 2006 Sep; 47(3):330-1. PubMed ID: 16047348
[TBL] [Abstract][Full Text] [Related]
9. Allopurinol Use During Maintenance Therapy for Acute Lymphoblastic Leukemia Avoids Mercaptopurine-related Hepatotoxicity.
Giamanco NM; Cunningham BS; Klein LS; Parekh DS; Warwick AB; Lieuw K
J Pediatr Hematol Oncol; 2016 Mar; 38(2):147-51. PubMed ID: 26808368
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia alarm enhancement using data fusion.
Skladnev VN; Tarnavskii S; McGregor T; Ghevondian N; Gourlay S; Jones TW
J Diabetes Sci Technol; 2010 Jan; 4(1):34-40. PubMed ID: 20167165
[TBL] [Abstract][Full Text] [Related]
11. The Continuous Glucose Monitoring System (CGMS) in type 1 diabetic children is the way to reduce hypoglycemic risk.
Schiaffini R; Ciampalini P; Fierabracci A; Spera S; Borrelli P; Bottazzo GF; Crinò A
Diabetes Metab Res Rev; 2002; 18(4):324-9. PubMed ID: 12203948
[TBL] [Abstract][Full Text] [Related]
12. Effect of short-term use of a continuous glucose monitoring system with a real-time glucose display and a low glucose alarm on incidence and duration of hypoglycemia in a home setting in type 1 diabetes mellitus.
Davey RJ; Jones TW; Fournier PA
J Diabetes Sci Technol; 2010 Nov; 4(6):1457-64. PubMed ID: 21129341
[TBL] [Abstract][Full Text] [Related]
13. Hypoglycemia and glycemic variability among children with acute lymphoblastic leukemia during maintenance therapy.
Trelinska J; Fendler W; Szadkowska A; Czerwoniuk D; Mianowska B; Wegner O; Mlynarski W
Leuk Lymphoma; 2011 Sep; 52(9):1704-10. PubMed ID: 21585281
[TBL] [Abstract][Full Text] [Related]
14. A novel analytical method for assessing glucose variability: using CGMS in type 1 diabetes mellitus.
McCall AL; Cox DJ; Crean J; Gloster M; Kovatchev BP
Diabetes Technol Ther; 2006 Dec; 8(6):644-53. PubMed ID: 17109596
[TBL] [Abstract][Full Text] [Related]
15. Reproducibility and reliability of hypoglycaemic episodes recorded with Continuous Glucose Monitoring System (CGMS) in daily life.
Høi-Hansen T; Pedersen-Bjergaard U; Thorsteinsson B
Diabet Med; 2005 Jul; 22(7):858-62. PubMed ID: 15975099
[TBL] [Abstract][Full Text] [Related]
16. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: experience of the Diabetes Research in Children Network.
Diabetes Research in Children Network (DirecNet) Study Group
Diabetes Care; 2004 Mar; 27(3):722-6. PubMed ID: 14988292
[TBL] [Abstract][Full Text] [Related]
17. Safety of various methods of intensive insulin therapy in hospital condition assessed by hypoglycaemic episodes detected with the use of continuous glucose monitoring system.
Mozdzan M; Ruxer J; Loba J; Siejka A; Markuszewski L
Adv Med Sci; 2006; 51():133-6. PubMed ID: 17357293
[TBL] [Abstract][Full Text] [Related]
18. Allopurinol reverses mercaptopurine-induced hypoglycemia in patients with acute lymphoblastic leukemia.
Zhang M; Bostrom B
F1000Res; 2019; 8():176. PubMed ID: 30828444
[TBL] [Abstract][Full Text] [Related]
19. A rare case of insulinoma presenting with postprandial hypoglycemia.
Shreenivas AV; Leung V
Am J Case Rep; 2014 Nov; 15():488-91. PubMed ID: 25381469
[TBL] [Abstract][Full Text] [Related]
20. Continuous glucose monitoring system in free-living healthy subjects: results from a pilot study.
Derosa G; Salvadeo SA; Mereu R; D'Angelo A; Ciccarelli L; Piccinni MN; Ferrari I; Gravina A; Maffioli P; Tinelli C
Diabetes Technol Ther; 2009 Mar; 11(3):159-69. PubMed ID: 19267581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
